These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 30122763

  • 21. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A, Rao JU, Lenders JW, Pellegata NS, Kusters B, Piscaer I, Hermus AR, Plantinga TS, Langenhuijsen JF, Vriens D, Janssen MJ, Gotthardt M, Timmers HJ.
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [Abstract] [Full Text] [Related]

  • 22. Risk-oriented approach to hereditary adrenal pheochromocytoma.
    Machens A, Brauckhoff M, Gimm O, Dralle H.
    Ann N Y Acad Sci; 2006 Aug; 1073():417-28. PubMed ID: 17102110
    [Abstract] [Full Text] [Related]

  • 23. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BA, Crossey PA, Maher ER, Brauch H.
    JAMA; 1995 Oct 11; 274(14):1149-51. PubMed ID: 7563486
    [Abstract] [Full Text] [Related]

  • 24. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
    Erlic Z, Hoffmann MM, Sullivan M, Franke G, Peczkowska M, Harsch I, Schott M, Gabbert HE, Valimäki M, Preuss SF, Hasse-Lazar K, Waligorski D, Robledo M, Januszewicz A, Eng C, Neumann HP.
    J Clin Endocrinol Metab; 2010 Jan 11; 95(1):308-13. PubMed ID: 19906784
    [Abstract] [Full Text] [Related]

  • 25. Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review.
    Jo KH, Lee J, Yoo J, Kim HS, Kim ES, Han JH, Jang YS, Yun JS, Son JW, Yoo SJ, Lee SH, Lim DJ, Kwon HS, Lee S, Moon S, Kim M.
    Ann Lab Med; 2024 Nov 01; 44(6):591-597. PubMed ID: 39069753
    [Abstract] [Full Text] [Related]

  • 26. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx.
    Gimm O.
    Fam Cancer; 2005 Nov 01; 4(1):17-23. PubMed ID: 15883706
    [Abstract] [Full Text] [Related]

  • 27. Familial nonsyndromic pheochromocytoma.
    Opocher G, Schiavi F, Iacobone M, Toniato A, Sattarova S, Erlic Z, Martella M, Mian C, Merante Boschin I, Zambonin L, De Lazzari P, Murgia A, Pelizzo MR, Favia G, Mantero F.
    Ann N Y Acad Sci; 2006 Aug 01; 1073():149-55. PubMed ID: 17102081
    [Abstract] [Full Text] [Related]

  • 28. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y, Nagai S, Yoshida M, Fujisawa S, Sazawa A, Shinohara N, Nonomura K, Matsuno K, Shimizu C.
    Endocr J; 2010 Aug 01; 57(8):745-50. PubMed ID: 20505258
    [Abstract] [Full Text] [Related]

  • 29. Rare presentation of familial paraganglioma without evidence of mutation in the SDH, RET and VHL genes: towards further genetic heterogeneity.
    Persu A, Amyere M, Gutierrez-Roelens I, Rustin P, Sempoux C, Lecouvet FE, Van Beers BE, Horsmans Y, De Plaen JF, MarcHamoir, Vikkula M.
    J Hypertens; 2009 Jan 01; 27(1):76-82. PubMed ID: 19145771
    [Abstract] [Full Text] [Related]

  • 30. Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: a systematic review.
    Brito JP, Asi N, Bancos I, Gionfriddo MR, Zeballos-Palacios CL, Leppin AL, Undavalli C, Wang Z, Domecq JP, Prustsky G, Elraiyah TA, Prokop LJ, Montori VM, Murad MH.
    Clin Endocrinol (Oxf); 2015 Mar 01; 82(3):338-45. PubMed ID: 24954084
    [Abstract] [Full Text] [Related]

  • 31. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
    Dong Y, Huang Y, Fan C, Wang L, Zhang R, Li W, Guo Z, Wang D, Zheng Z.
    Cell Death Dis; 2021 May 04; 12(5):444. PubMed ID: 33947839
    [Abstract] [Full Text] [Related]

  • 32. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.
    Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Sköldberg F, Husebye ES, Eng C, Maher ER.
    Am J Hum Genet; 2001 Jul 04; 69(1):49-54. PubMed ID: 11404820
    [Abstract] [Full Text] [Related]

  • 33. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?
    Jiménez C, Cote G, Arnold A, Gagel RF.
    J Clin Endocrinol Metab; 2006 Aug 04; 91(8):2851-8. PubMed ID: 16735498
    [Abstract] [Full Text] [Related]

  • 34. Genetics of pheochromocytoma and paraganglioma in Spanish patients.
    Cascón A, Pita G, Burnichon N, Landa I, López-Jiménez E, Montero-Conde C, Leskelä S, Leandro-García LJ, Letón R, Rodríguez-Antona C, Díaz JA, López-Vidriero E, González-Neira A, Velasco A, Matias-Guiu X, Gimenez-Roqueplo AP, Robledo M.
    J Clin Endocrinol Metab; 2009 May 04; 94(5):1701-5. PubMed ID: 19258401
    [Abstract] [Full Text] [Related]

  • 35. Pheochromocytoma: the expanding genetic differential diagnosis.
    Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL.
    J Natl Cancer Inst; 2003 Aug 20; 95(16):1196-204. PubMed ID: 12928344
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
    Jafri M, Whitworth J, Rattenberry E, Vialard L, Kilby G, Kumar AV, Izatt L, Lalloo F, Brennan P, Cook J, Morrison PJ, Canham N, Armstrong R, Brewer C, Tomkins S, Donaldson A, Barwell J, Cole TR, Atkinson AB, Aylwin S, Ball SG, Srirangalingam U, Chew SL, Evans DG, Hodgson SV, Irving R, Woodward E, Macdonald F, Maher ER.
    Clin Endocrinol (Oxf); 2013 Jun 20; 78(6):898-906. PubMed ID: 23072324
    [Abstract] [Full Text] [Related]

  • 37. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP, Weiss MM, Grimbergen A, van Brussel BT, Hes FJ, Jansen JC, Verhoef S, Devilee P, Corssmit EP, Vriends AH.
    Endocr Relat Cancer; 2009 Sep 20; 16(3):929-37. PubMed ID: 19546167
    [Abstract] [Full Text] [Related]

  • 38. Mutation screening in a Norwegian cohort with pheochromocytoma.
    Sjursen W, Halvorsen H, Hofsli E, Bachke S, Berge A, Engebretsen LF, Falkmer SE, Falkmer UG, Varhaug JE.
    Fam Cancer; 2013 Sep 20; 12(3):529-35. PubMed ID: 23407919
    [Abstract] [Full Text] [Related]

  • 39. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?
    Erlic Z, Neumann HP.
    Clin Endocrinol (Oxf); 2009 Mar 20; 70(3):354-7. PubMed ID: 19067729
    [Abstract] [Full Text] [Related]

  • 40. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G, Stanojević B, Palmar I, Dimitrijević B.
    Srp Arh Celok Lek; 2002 Jul 20; 130 Suppl 2():52-7. PubMed ID: 12584999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.